CompanyGraph
What stands out
- Pays more per share than it earned over the last twelve months
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- PositionCurrent ratio is 11.2×, higher than 95% of its Medical Instruments & Supplies peers (median 2.2×)
- FinancialsAltman Z-Score 8.97: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
What stands out
- Pays more per share than it earned over the last twelve months
Dividends view
Yield
4.25%Below 5Y avg (5.03%)
Annual Rate
CNY 2.00Paid semi-annual
Payout Ratio
114.3%High
Payback Period
24.9 yr
Last Ex-Dividend
Jun 1, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.55BCNY530.54M · vs all stocks (USD)
Trailing P/E
26.25xvs Medical Instruments & Supplies peers
Revenue (TTM)
867.64MCNY129.51M · vs all stocks (USD)
Profit Margin
16.02%vs Medical Instruments & Supplies peers
Beta
0.1660xvs all stocks
52-Week Change
-30.31%vs all stocks
Forward Annual Dividend Yield
4.25%vs all stocks
Market Capitalization
3.55BCNY530.54M · vs all stocks (USD)
Enterprise Value
1.36BCNY203.57M · vs all stocks (USD)
Trailing P/E
26.25xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
4.00xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
0.9536xvs Medical Instruments & Supplies peers
Enterprise to Revenue
1.57xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
8.12xvs Medical Instruments & Supplies peers
Gross Margin
53.26%vs Medical Instruments & Supplies peers
Profit Margin
16.02%vs Medical Instruments & Supplies peers
Operating Margin
16.88%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
1.87%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
3.62%vs Medical Instruments & Supplies peers
Revenue (TTM)
867.64MCNY129.51M · vs all stocks (USD)
Revenue per Share (TTM)
10.93CNYUpdated Sep 22, 2026Quarterly Revenue Growth
-11.10%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
421.86MCNY62.97M · vs all stocks (USD)
EBITDA (TTM)
130.32MCNY19.45M · vs all stocks (USD)
Net Income (TTM)
139.02MCNY20.75M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-55.60%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
198.12MCNY29.57M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-20.31MCNY-3.03M · vs all stocks (USD)
Forward Annual Dividend Rate
2.00CNYUpdated Sep 22, 2026Forward Annual Dividend Yield
4.25%vs all stocks
Trailing Annual Dividend Rate
2.00CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
4.25%vs all stocks
5-Year Average Dividend Yield
5.03%vs all stocks
Payout Ratio
114.29%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
-352.02KCNYFY2025 · Dec 31, 2025Revenue
905.34MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
444.09MCNYFY2025 · Dec 31, 2025Gross Profit
461.25MCNYFY2025 · Dec 31, 2025Operating Income
207.24MCNY30.93M · vs all stocks (USD)
Pre-tax Income
251.18MCNYFY2025 · Dec 31, 2025Income Tax Expense
31.10MCNYFY2025 · Dec 31, 2025Net Income
220.07MCNYFY2025 · Dec 31, 2025EBIT
251.46MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
259.81MCNYFY2025 · Dec 31, 2025Research & Development
109.32MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
76.58MCNYFY2025 · Dec 31, 2025Other Operating Expenses
9.55MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
25.49MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
280.38KCNYFY2025 · Dec 31, 2025EPS (Basic)
2.78CNYFY2025 · Dec 31, 2025EPS (Diluted)
2.78CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
79.21MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
79.21MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
220.07MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
119.99KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
137.34MCNYFY2025 · Dec 31, 2025Free Cash Flow
-81.07MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.06BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
220.07MCNYFY2025 · Dec 31, 2025Other Non-cash Items
15.30MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-77.63MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-20.41MCNYFY2025 · Dec 31, 2025Capital Expenditures
-218.41MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.73BCNYFY2025 · Dec 31, 2025Sale of Investments
2.08BCNYFY2025 · Dec 31, 2025Other Investing Activity
15.71MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
145.67MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-195.11MCNYFY2025 · Dec 31, 2025Other Financing Charges
17.10MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-178.01MCNYFY2025 · Dec 31, 2025Shares Outstanding
79.28MSharesUpdated Sep 22, 2026Float Shares
26.76MSharesUpdated Sep 22, 2026% Held by Insiders
65.25%vs all stocks
% Held by Institutions
7.03%vs all stocks
Total Cash (MRQ)
2.12BCNY317.07M · vs all stocks (USD)
Total Cash per Share (MRQ)
28.02CNYUpdated Sep 22, 2026Total Debt (MRQ)
7.03MCNY1.05M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0019xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
11.20xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
48.16CNYUpdated Sep 22, 2026Total Assets
4.24BCNY633.27M · vs all stocks (USD)
Total Current Assets
2.83BCNYFY2025 · Dec 31, 2025Total Liabilities
296.09MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.41BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
9.44MCNYFY2025 · Dec 31, 2025Total Current Liabilities
286.64MCNYFY2025 · Dec 31, 2025Cash
1.07BCNYFY2025 · Dec 31, 2025Cash Equivalents
436.74KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.07BCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.32BCNYFY2025 · Dec 31, 2025Accounts Receivable
159.05MCNYFY2025 · Dec 31, 2025Inventory
176.69MCNYFY2025 · Dec 31, 2025Accounts Payable
120.05MCNYFY2025 · Dec 31, 2025Short-term Debt
544.67KCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.19MCNYFY2025 · Dec 31, 2025Long-term Debt
6.87MCNYFY2025 · Dec 31, 2025Common Stock (Book)
79.28MCNYFY2025 · Dec 31, 2025Retained Earnings
1.94BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.95BCNY589.07M · vs all stocks (USD)
Treasury Stock
47.41MCNYFY2025 · Dec 31, 202552-Week Low
39.80CNYUpdated Sep 22, 202652-Week High
72.88CNYUpdated Sep 22, 202652-Week Change
-30.31%vs all stocks
Beta
0.1660xvs all stocks
50-Day MA
45.77CNYUpdated Sep 22, 2026200-Day MA
55.84CNYUpdated Sep 22, 2026Avg 10-Day Volume
187.65KSharesUpdated Sep 22, 2026Avg 30-Day Volume
363.83KSharesUpdated Sep 22, 2026Diluted EPS (TTM)
1.75CNYUpdated Sep 22, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
Retained Earnings Heavy With Elevated Payout
Profits kept in the business fund much of what it owns, and it now pays out most of what it earns.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 11.2×, higher than 95% of its Medical Instruments & Supplies peers (median 2.2×)Significant
Current ratio: 11.20Industry median: 2.20Industry P95: 10.55Peers compared: 62.00
Debt-to-equity is 0×, lower than 95% of its Medical Instruments & Supplies peers (median 0.23×)Notable
Debt-to-equity: 0.00Industry median: 0.23Industry P5: 0.00Peers compared: 62.00
Structural Tensions
Pays more per share than it earned over the last twelve monthsSignificant
Payout Ratio: 1.14Dividend per Share: 2.00Earnings per Share: 1.75
Financial Health
Altman Z-Score 8.97: safe zoneNotable
Altman Z-Score: 8.97
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Singatron Electronic China, Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Bestek Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Rijiu Optoelectronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Sebang Global Battery Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Texmaco Rail & Engineering Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangxi Chenguang New Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Sf Oilless Bearing Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
G-Tekt Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sinon Corporation
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Yonz Technology Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Guangzhou Haoyang Electronic Co., Ltd.
3 interpretationsHigh Retained Earnings With Profitability And EquityRetained Earnings Heavy With Elevated PayoutLow-Leverage Liquidity Configuration
Allied Supreme Corporation
3 interpretationsHigh Retained Earnings With Profitability And EquityRetained Earnings Heavy With Elevated PayoutLow-Leverage Liquidity Configuration
Yantai Zhenghai Bio-Tech Co., Ltd.
2 interpretationsHigh Retained Earnings With Profitability And EquityRetained Earnings Heavy With Elevated Payout